Shirley, NY -- (ReleaseWire) -- 09/02/2024 -- Creative Biogene, with over a decade of expertise in NGS primer synthesis, stands at the forefront of providing tailored primer solutions for a diverse range of research and clinical applications. Leveraging advanced synthesis technologies and stringent quality control measures, Creative Biogene offers customized NGS primer services encompassing library adapters to hybrid capture probes.

The rapid advancements in Next Generation Sequencing (NGS) technology have heralded a new era of innovation in scientific research and medical diagnosis. Since its inception in 2005, NGS technology has seen significant enhancements in sequencing speed, throughput, and accuracy, serving as a transformative tool for the exploration of complex biological problems, genetic variations, disease mechanisms, and personalized medicine. The evolution of NGS technology has paved the way for a higher technical platform and broader application prospects, reshaping the landscape of genomics research and diagnostics.

"Our commitment to excellence in NGS primer synthesis underscores our dedication to empowering researchers and healthcare professionals with reliable tools for their genomics endeavors," said a spokesperson for Creative Biogene. "We recognize the critical role that primers play in NGS experiments, and our comprehensive primer solutions are designed to meet the evolving needs of the scientific and medical communities."

Creative Biogene's NGS primer services cater to a wide spectrum of research requirements, including whole-genome sequencing, targeted gene panels, and RNA sequencing. By incorporating cutting-edge technologies and meticulous quality assurance processes, Creative Biogene ensures that researchers receive primers of the highest standard, enabling them to achieve precise and reproducible sequencing results.

With the continuous progression of NGS technology, the demand for high-quality primers that uphold the standards of accuracy and efficiency has never been more pronounced. Creative Biogene remains steadfast in its commitment to meeting these demands, offering unparalleled expertise and support to researchers and clinicians seeking to harness the full potential of NGS technology in their investigations.

About Creative Biogene
Creative Biogene is a trusted provider of cutting-edge solutions in molecular biology, offering a wide array of products and services to support research, diagnostics, and drug discovery. With a focus on innovation, quality, and customer-centricity, Creative Biogene is dedicated to empowering scientists and healthcare professionals worldwide to achieve groundbreaking advancements in the field of life sciences.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Shirley, NY -- (ReleaseWire) -- 09/02/2024 -- As a leading provider of therapeutic oligonucleotides, IntegrateRNA is proud to offer a comprehensive range of custom synthesis and manufacturing services to support the development of novel nucleic acid-based therapeutics. With a focus on innovation and cutting-edge technology, IntegrateRNA is dedicated to helping researchers and pharmaceutical companies bring their therapeutics from concept to reality.

At IntegrateRNA, we understand the importance of customized solutions to meet the specific needs of our clients. That is why we are excited to announce the introduction of our custom 2'-O-hexadecyl (C16)-siRNA conjugates. These conjugates are designed to enhance the stability, cellular uptake, and targeting ability of siRNA/oligonucleotide molecules, providing significant advantages in the development of nucleic acid-based therapeutics.

The incorporation of a hexadecyl (C16) lipid moiety at the 2'-O position of the ribose sugar in the siRNA molecule allows for improved stability in biological systems. This modification increases the resistance of the siRNA to nucleases, enzymes that degrade RNA molecules, thus prolonging the half-life of the therapeutic molecule and enhancing its efficacy in target tissues. Additionally, the lipid moiety aids in cellular uptake, facilitating the delivery of the siRNA to its intracellular target sites. This improved cellular uptake not only enhances the potency of the therapeutic molecule but also reduces the amount required for effective treatment, thereby minimizing potential side effects.

Furthermore, the hexadecyl (C16) lipid moiety provides a hydrophobic anchor that can interact with cell membranes, enabling more efficient targeting of specific cell types. This targeted delivery mechanism increases the precision of the therapeutic molecule, reducing off-target effects and enhancing overall therapeutic efficacy. By offering custom 2'-O-hexadecyl (C16)-siRNA conjugates, IntegrateRNA empowers researchers and pharmaceutical companies to optimize the design of their nucleic acid-based therapeutics for improved clinical outcomes.

In addition to our custom synthesis services, IntegrateRNA also provides comprehensive manufacturing capabilities to support the scale-up and production of therapeutic oligonucleotides. Our state-of-the-art facilities and experienced team ensure the highest quality and consistency in the manufacturing process, meeting regulatory requirements and industry standards.

About IntegrateRNA
IntegrateRNA is committed to advancing the field of nucleic acid-based therapeutics through innovative solutions and exceptional customer service. Our custom 2'-O-hexadecyl (C16)-siRNA conjugates represent a significant advancement in the development of targeted and potent nucleic acid-based therapeutics, offering researchers and pharmaceutical companies a valuable tool in their quest for effective treatments.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Shirley, NY -- (ReleaseWire) -- 09/02/2024 -- Microbiosci, a division of Creative Biogene and a leading company in the field of genetic research, is proud to offer top-notch CRISPR/Cas9-mediated genome editing services. Our team of talented scientists boasts extensive experience in gene knockout, knock-in/replacement, and site-directed mutagenesis, ensuring the highest quality and precision in our work. We collaborate closely with our clients to provide tailored assistance in microbial genome editing, catering to a wide range of research needs.

Our cutting-edge technology involves reprogramming various CRISPR?Cas systems, including CRISPR?Cas9, CRISPR?Cas12a, and CRISPR?Cas12f1, to achieve precise gene editing, such as knock-out, knock-in, and point mutation, at specific target locations within the genome of diverse cells. These Cas proteins serve as reprogrammable and highly specific genome editing tools, enabling us to deliver unparalleled results in genetic modification and manipulation.

"At Microbiosci, we are dedicated to pushing the boundaries of genetic engineering and providing our clients with innovative solutions for their research projects," said a spokesperson for the company. "Our expertise in CRISPR/Cas9-mediated genome editing allows us to offer unparalleled precision and customization, ensuring that each project is conducted with the utmost care and attention to detail."

Whether you are conducting basic research, drug development, or agricultural studies, Microbiosci's genome editing services can help accelerate your work and achieve your desired outcomes efficiently. By leveraging the latest advancements in genetic technology and working closely with our team of experts, you can unlock the full potential of CRISPR/Cas9-mediated genome editing and drive groundbreaking discoveries in your field.

To learn more about Microbiosci's CRISPR/Cas9-mediated genome editing services and how we can assist you with your research needs, please visit our website at www.microbiosci.com or contact us directly to discuss your project requirements. Experience the difference that our expertise and dedication to excellence can make in advancing your genetic research endeavors.

About Microbiosci
Microbiosci is a division of Creative Biogene, a leading provider of cutting-edge genetic research solutions. With a focus on CRISPR/Cas9-mediated genome editing services, Microbiosci offers unparalleled expertise and technology to support a variety of research applications, from basic science to drug development and beyond. Partner with us to realize the full potential of genetic engineering and drive innovation in your research projects.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm